PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Kidney Research and Clinical Practice10.23876/j.krcp.2017.36.2.2002017362200-204Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapyJun-Seop Kim, Jong-Hak Lee, Owen Kwon, Jang-Hee Cho, Ji-Young Choi, Sun-Hee Park, Chan-Duck Kim, Yong-Jin Kim, Yong-Lim Kimhttp://pdf.medrang.co.kr/KRCP2/2017/036/KRCP036-02-11.pdf, http://pdf.medrang.co.kr/KRCP2/2017/036/KRCP036-02-11.pdf
Stem Cell Research & Therapy10.1186/scrt472201454Mesenchymal stem cell treatment for chronic renal failureAlfonso Eirin, Lilach O Lermanhttps://link.springer.com/content/pdf/10.1186/scrt472.pdf, https://link.springer.com/article/10.1186/scrt472/fulltext.html, https://link.springer.com/content/pdf/10.1186/scrt472.pdf
Stem Cell Research & Therapy10.1186/scrt157201341Among mesenchymal stem cells: for the best therapy after ischemic strokeYuka Ikegamehttps://link.springer.com/content/pdf/10.1186/scrt157.pdf, https://link.springer.com/article/10.1186/scrt157/fulltext.html, https://link.springer.com/content/pdf/10.1186/scrt157.pdf
Pediatric Transplantation10.1034/j.1399-3046.2003.00071.x200375408-412End-stage renal disease after high-dose carboplatinum in preparation of autologous stem cell transplantationLavjay Butani, Daniel C. West, Douglas S. Taylorhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1399-3046.2003.00071.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1399-3046.2003.00071.x, http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1399-3046.2003.00071.x/fullpdf
Molecular Therapy10.1016/s1525-0016(16)44497-7200715S110291. Phase 1 Human Trial of Autologous Mesenchymal Stem Cell Transplantation for the Treatment of Decompensated Cirrhosishttps://api.elsevier.com/content/article/PII:S1525001616444977?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525001616444977?httpAccept=text/plain
Stem Cell Reviews and Reports10.1007/s12015-014-9495-22014103351-375Interferon-Gamma Modification of Mesenchymal Stem Cells: Implications of Autologous and Allogeneic Mesenchymal Stem Cell Therapy in AllotransplantationKisha Nandini Sivanathan, Stan Gronthos, Darling Rojas-Canales, Benjamin Thierry, P. Toby Coateshttp://link.springer.com/content/pdf/10.1007/s12015-014-9495-2.pdf, http://link.springer.com/article/10.1007/s12015-014-9495-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12015-014-9495-2
Stem Cell Research & Therapy10.1186/s13287-020-02067-x2020111Autologous adipose mesenchymal stem cell administration in arteriosclerosis and potential for anti-aging application: a retrospective cohort studyHiroki Ohta, Xiaolan Liu, Miho Maedahttp://link.springer.com/content/pdf/10.1186/s13287-020-02067-x.pdf, http://link.springer.com/article/10.1186/s13287-020-02067-x/fulltext.html, http://link.springer.com/content/pdf/10.1186/s13287-020-02067-x.pdf
Stem Cells and Development10.1089/scd.2017.0025201726141042-1053Intrinsic Mesenchymal Stem Cell Dysfunction in Diabetes Mellitus: Implications for Autologous Cell TherapyMari van de Vyverhttps://www.liebertpub.com/doi/full-xml/10.1089/scd.2017.0025, https://www.liebertpub.com/doi/pdf/10.1089/scd.2017.0025
Cytotherapy10.1016/j.jcyt.2017.02.0142017195S10-S11Autologous mesenchymal stem cell therapy in behcet diseaseH. Gabr, W. Abo Elkheir, Y. Abo Elkheirhttps://api.elsevier.com/content/article/PII:S1465324917300725?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1465324917300725?httpAccept=text/plain
Cytotherapy10.1016/j.jcyt.2016.03.0382016186S14Systemic Autologous Mesenchymal Stem Cell Therapy for Immunomodulation in Resistant Myasthenia GravisH. Gabr, W. Abo Elkheirhttps://api.elsevier.com/content/article/PII:S1465324916300627?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1465324916300627?httpAccept=text/plain